Article contents
Left hemispheric reductions of regional cerebral blood flow (rCBF) correlate with measures of dementia severity in patients with Alzheimer's disease: a SPECT study
Published online by Cambridge University Press: 16 April 2020
Summary
Regional cerebral blood flow (rCBF) values were measured by single photon emission computed tomography (SPECT) in different regions of the brain in 27 patients with DAT. Significant correlations were found between rCBF in left parieto-temporooccipital regions and psychometric test scores. Patients with hemisphere asymmetry in SPECT performed worse on psychometric tests. SPECT did not permit prediction of or differentiation between depressive and psychotic symptoms.
- Type
- Short communication
- Information
- Copyright
- Copyright © Elsevier, Paris 1996
References
Celsis, P, Agniel, A, Puel, M, et al.Lateral asymmetries in primary degenerative dementia of the Alzheimer type. A correlative study of cognitive, haemodynamic and EEG data, in relation with severity, age of onset and sex Cortex 1990 26 585–596CrossRefGoogle ScholarPubMed
DeKosky, ST, Shih, WJ, Schmitt, FA, Coupal, J, Kirkpatrick, CAssessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer's disease: correlation with cognitive severity Alzheimer Dis Assoc Disord 1990 4 14–23CrossRefGoogle ScholarPubMed
Dewan, MJ, Gupta, SToward a definitive diagnosis of Alzheimer’s disease Compr Psychiatry 1992 33 282–290CrossRefGoogle Scholar
Dilling, H, Mombour, W, Schmidt, MHInternationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F), kli-nisch-diagnostische Leitlinien, Weltgesundheitsorganisation (WHO) Bern, Göttingen, TorontoHuber 1991Google Scholar
Eagger, S, Syed, GM, Burns, A, Barrett, JJ, Levy, RMorphologic (CT) and functional (rCBF-SPECT) correlates in Alzheimer’s disease Nucl Med Commun 1992 13 644–647CrossRefGoogle ScholarPubMed
Erzigkeit, HThe SKT — a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancersBergener, MReisberg, BDiagnosis and Treatment of Senile Dementia Berlin, Heidelberg, New YorkSpringer 1989 164–174CrossRefGoogle Scholar
Folstein, MF, Folstein, SE, McHugh, PR"Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975 12 189–198CrossRefGoogle ScholarPubMed
Frölich, L, Eilles, C, Ihl, R, Maurer, K, Lanczik, MStage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type Psychiatry Res 1989 29 347–350CrossRefGoogle Scholar
Gemmel, HG, Sharp, PF, Besson, JA, et al.Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study J Comput Assist Tomogr 1987 398–402CrossRefGoogle Scholar
Goldenberg, G, Podreka, I, Suess, E, Deecke, LThe cerebral localization of neuropsychological impairment in Alzheimer’s disease: a SPECT study J Neurol 1989 236 131138CrossRefGoogle ScholarPubMed
Ihl, R, Frölich, L, Dierks, T, Martin, EM, Maurer, KDifferential validity of psychometric tests in dementia of the Alzheimer type Psychiatry Res 44 1992 93–106CrossRefGoogle ScholarPubMed
Jagust, WJFunctional imaging in dementia: an overview J Clin Psychiatry 1994 55Suppl 115–11Google ScholarPubMed
Kincaid, MM, Harvey, PD, Parrella, M, et al.Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients J Neu-ropsychiatry Clin Neurosci 1995 7 76–81Google ScholarPubMed
Markus, HS, Ring, H, Kouris, K, Costa, DCAlterations in regional cerebral blood flow, with increased temporal interhemispheric asymmetries, in the normal elderly: an HMPAO SPECT study Nucl Med Commun 1993 14 628–633CrossRefGoogle ScholarPubMed
Mayberg, HSClinical correlates of PET-and SPECT-identified defects in dementia J Clin Psychiatry 1994 55suppl 11 12–21Google Scholar
McKhann, G, Drachmann, D, Folstein, MClinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 1984 34 939–944CrossRefGoogle ScholarPubMed
Mohs, RC, Rosen, WG, Davis, KLThe Alzheimer's disease assessment scale: An instrument for assessing treatment efficacy Psychopharmacol Bull 1983 19 448–450Google ScholarPubMed
Montaldi, D, Brooks, DN, McColl, JH, Wyper, D, Patterson, J, Barren, E, McCulloch, JMeasurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease J Neurol Neurosurg Psychiatry 1990 53 33–38CrossRefGoogle ScholarPubMed
O'Brien, JT, Eagger, S, Syed, GM, Sahakian, BJ, Levy, RA study of regional cerebral blood flow and cognitive performance in Alzheimer’s disease J Neurol Neurosurg Psychiatry 1992 55 1182–1187CrossRefGoogle ScholarPubMed
Reisberg, B, Schneck, MK, Ferris, SH, Schwartz, GE, deLeon, MJThe brief cognitive rating scale (BCRS): Findings in primary degenerative dementia (PDD) Psychopharmacol Bull 1983 19 47–50Google Scholar
Rosen, WG, Terry, RD, Fuld, PA, Katzman, R, Peck, APathologic verification of ischemic score in differentiation of dementias Ann Neurol 1980 7 486–488CrossRefGoogle Scholar
Waldemar, G, Walovitch, RC, Andersen, AR, et al.99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial J Cereb Blood Flow Metab 1994 14suppl 1 S99–S105Google ScholarPubMed
Weintraub, S, Mesulam, MMFour neuropsychological profiles in dementiaSpinnler, HBoiler, FHandbook of Neuropsychology vol 8 AmsterdamElsevier 1993 253–282Google Scholar
Zec, RF, Landreth, ES, Vicari, SK, et al.Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type Alzheimer Dis Assoc Disord 1992 6 89–102CrossRefGoogle ScholarPubMed
- 3
- Cited by
Comments
No Comments have been published for this article.